Corvese Brian
Insider CIK 1393207 · PTIX Director · AGEN Director · INKT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INKT MiNK Therapeutics, Inc. | A Award | 2026-09-01 | 2026-09-02 | 1,633 | $10.95 | $17.9K | 54,770 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2026-09-01 | 2026-09-02 | 1,633 | $10.95 | $17.9K | 54,770 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-08-05 | 2026-08-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-08-05 | 2026-08-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2026-06-01 | 2026-06-02 | 1,444 | $12.38 | $17.9K | 53,137 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-04-24 | 2026-04-28 | 210,000 | — | $0 | 210,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2026-03-02 | 2026-06-02 | 1,640 | $10.90 | $17.9K | 51,693 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 5,395 | — | $0 | 5,395 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2025-12-01 | 2025-12-03 | 1,612 | $11.09 | $17.9K | 50,053 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2025-09-09 | 2025-09-11 | 3,225 | — | $0 | 3,225 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2025-09-02 | 2025-09-03 | 1,290 | $13.86 | $17.9K | 48,441 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2025-06-17 | 2025-06-20 | 750 | — | $0 | 750 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2025-06-17 | 2025-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2025-06-02 | 2025-06-04 | 2,494 | $7.17 | $17.9K | 47,151 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2025-03-03 | 2025-03-05 | 2,033 | $8.79 | $17.9K | 44,657 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2024-12-01 | 2024-12-03 | 24,400 | $0.73 | $17.8K | 426,283 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2024-09-03 | 2024-09-05 | 21,802 | $0.82 | $17.9K | 405,296 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2024-06-11 | 2024-06-18 | 750 | — | $0 | 750 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2024-06-03 | 2024-06-05 | 17,967 | $0.99 | $17.8K | 383,494 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2024-03-25 | 2024-03-29 | 43,750 | $1.74 | $76.1K | 43,750 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-05 | 18,816 | $0.95 | $17.9K | 365,527 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2024-02-05 | 2024-04-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2023-12-01 | 2023-12-05 | 17,188 | $1.04 | $17.9K | 346,711 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2023-09-01 | 2023-09-06 | 12,244 | $1.46 | $17.9K | 329,523 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 37,500 | — | $0 | 37,500 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2023-06-01 | 2023-06-02 | 10,157 | $1.76 | $17.9K | 317,505 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-03 | 8,553 | $2.09 | $17.9K | 307,348 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2022-12-01 | 2022-12-05 | 6,849 | $2.61 | $17.9K | 298,795 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2022-09-15 | 2022-09-19 | 13,646 | $2.62 | $35.8K | 13,646 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2022-03-09 | 2022-03-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2022-02-04 | 2022-02-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AGEN AGENUS INC | M Exercise deriv | 2021-06-16 | 2021-06-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| AGEN AGENUS INC | M Exercise | 2021-06-16 | 2021-06-21 | 22,471 | — | $0 | 92,085 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2021-06-15 | 2021-07-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2020-12-17 | 2020-12-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AGEN AGENUS INC | M Exercise deriv | 2020-06-19 | 2020-06-23 | 21,118 | — | $0 | 0 | SEC↗ |
| AGEN AGENUS INC | M Exercise | 2020-06-19 | 2020-06-23 | 21,118 | — | $0 | 69,614 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2020-06-16 | 2020-06-17 | 22,471 | — | $0 | 49,589 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2020-06-16 | 2020-06-17 | 2,500 | — | $0 | 2,500 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2020-02-21 | 2020-02-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-12-24 | 2019-12-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-06-19 | 2019-06-21 | 27,118 | — | $0 | 27,118 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-06-19 | 2019-06-21 | 2,500 | — | $0 | 2,500 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-06-19 | 2019-06-21 | 100,000 | — | $0 | 102,500 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-06-20 | 2018-06-22 | 21,276 | — | $0 | 21,276 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-06-20 | 2018-06-22 | 37,500 | $5.65 | $211.9K | 37,500 | SEC↗ |
| AGEN AGENUS INC | M Exercise deriv | 2018-03-31 | 2018-04-03 | 21,220 | — | $0 | 0 | SEC↗ |
| AGEN AGENUS INC | M Exercise | 2018-03-31 | 2018-04-03 | 21,220 | — | $0 | 21,220 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2017-10-16 | 2017-10-18 | 95,000 | — | $0 | 95,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2017-06-29 | 2017-07-03 | 2,500 | $3.91 | $9.8K | 2,500 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2017-06-29 | 2017-07-03 | 50,000 | $3.91 | $195.5K | 50,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2017-03-31 | 2017-04-04 | 21,220 | — | $0 | 21,220 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2017-03-16 | 2017-03-20 | 4,166 | $4.16 | $17.3K | 4,166 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2016-06-15 | 2016-06-17 | 35,000 | $3.91 | $136.8K | 35,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2015-06-25 | 2015-06-29 | 18,750 | $8.43 | $158.1K | 18,750 | SEC↗ |
| AGEB AGENUS INC | A Award deriv | 2014-04-24 | 2014-04-29 | 15,000 | $2.71 | $40.6K | 15,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2012-06-14 | 2012-06-18 | 15,000 | $5.34 | $80.1K | 34,166 | SEC↗ |